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Aim: We performed a retrospective, analytical study in February 2010 on all retinitis pigmentosa 
cases seen during ophthalmologic consultation at the Gyneco-Obstetrics and Pediatric Hospital 
of Yaounde between March 2002 and December 2009 (82 months). The aim of this research 
was to determine the significance of blindness and visual impairment associated with retinitis 
pigmentosa in Cameroon.
Results: Forty cases were reported, corresponding to a hospital prevalence of 1.6/1000 (21 men 
and 19 women). The average age of the patients was 43.3 ± 18 years, ranging between 6 and 
74 years. Bilateral blindness and low vision was noted in 30% and 27.5% of patients, respec-
tively. The average age of patients with low vision was 40.38 ± 16.27 years and the average age 
of those with bilateral blindness was 51.08 ± 15.79 years. Retinitis pigmentosa was bilateral in 
all cases and isolated (without any eye or general additional disease) in 67.5% of cases.
Conclusion: Visual impairment is common and becomes even more severe with aging. Patients 
should be screened to enable them to benefit from management focusing on both appropriate 
treatment and genetic counseling.
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Introduction
Retinitis pigmentosa is a genetic disorder with diffuse retinal dystrophy which, in most 
cases, primarily affects the rods initially, with subsequent degeneration of cones. Its 
prevalence ranges from 1/3000 to 1/5000.1,2 Transmission of retinitis pigmentosa is 
genetic and may be by various modes, ie, autosomal dominant, autosomal recessive, or 
X-linked recessive.3 Retinitis pigmentosa is a leading cause of blindness and incurable 
visual impairment, owing to its irreversible evolution towards loss of central vision. 
We undertook this work in order to determine for the first time the significance of 
blindness and visual impairment associated with retinitis pigmentosa in Cameroon.
Methods
A retrospective study was carried out on all retinitis pigmentosa cases seen in the out-
patients’ clinic at the Ophthalmological Unit of the Gyneco-Obstetrics and Pediatric 
Hospital of Yaoundé between March 2002 and December 2009 (82 months). The files of 
patients with retinitis pigmentosa were reviewed. The diagnosis of retinitis pigmentosa 
was made on the basis of an examination of the ocular fundus using a biomicroscope, 
the three ophthalmoscopic criteria being retinal hyperpigmentation in star clusters 
(osteoblasts), arterial narrowing, and waxy pallor of the papilla. Far visual acuity on 
the Snellen scale, intraocular pressure using an air-pulse tonometer, abnormalities in Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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the anterior segment, and the ocular fundus of each patient 
were also noted. Performance of additional examinations, 
ie, automatic visual field and retinal angiography was not 
systematic, and few patients, for financial reasons, had visual 
field assessment. Electroretinography (ERG) and genetic tests 
were not performed in our study due to the inadequate level 
of technical expertise at the unit.
The variables analyzed were age, gender, main complaint, 
far visual acuity, intraocular pressure, ocular fundus, and 
visual field. The chi-squared test was used for comparison, 
and was considered significant at P , 0.05.
The classification of visual impairment was made using 
the analysis of visual acuity as defined by the World Health 
Organization,4 ie, binocular blindness (visual acuity ,1/20 
of the better eye with correction, and low vision (visual 
acuity ,3/10 and $1/20 of the better eye with correction). 
We considered any patient with a corrected visual acuity of 
the better eye .3/10 and that of the impaired eye ,1/20 as 
having monocular blindness.
Results
Of 24,205 files selected for study, 40 cases of retinitis 
pigmentosa were identified, corresponding to a hospital 
prevalence of 1.6/1000. The disease was noted in 21 men and 
19 women. The average age of patients was 43.3 ± 18.2 years, 
with a range of 6–74 years. The most represented age group 
was 41–50 years, which included 11 patients (27.5%), fol-
lowed by patients aged .60 years (eight cases, 20%), with 
only four cases (10%) ,20 years. In total, 24 patients (60%) 
were .40 years (Table 1).
The main complaint was a drop in visual acuity, which 
was found in 35 patients (87.5%), followed by night blindness 
in 28 patients (70%). It should be noted that a single patient 
could have several reasons for consultation. With regard 
to family history, we noted 10 cases (25%) of a history of 
blindness in relatives, but the cause of this blindness was 
unknown to the patient or the family. No case of parental 
consanguinity was reported. In addition, retinitis pigmentosa 
was not diagnosed in siblings of affected patients, in cases 
where brothers and/or sisters attended an ophthalmologic 
consultation requested by the attending physician.
The analysis of visual acuity revealed binocular blindness 
in 12 patients (30%) and low vision in 11 cases (27.5%, see 
Figure 1). One case of monocular blindness was noted in a 
patient with a unilateral macular hole.
Six of 11 patients (54.54%) with low vision were older 
than 40 years and nine of 12 cases (75%) of bilateral blind-
ness were recorded in patients older than 40 years (Table 2). 
The average age of patients with low vision was 40.38 ± 
16.27 years and that of patients with bilateral blindness was 
51.08 ± 15.79 years.
The average intraocular pressure observed was 14.30 ± 
2.86 mmHg and 14.83 ± 5.24 mmHg in the right eye and left 
eye, respectively. The intraocular pressure was above normal 
(21 mmHg) in three eyes from three different patients.
Retinitis pigmentosa was bilateral in all our patients, 
and isolated (without any other eye or additional disease) 
in 27 cases (67.5%). The major associated pathologies were 
cataract (four cases), chronic open angle glaucoma (three 
cases), age-related macular degeneration (ARMD, three 
cases), and high myopia (two cases, Table 3). No deafness 
was noticed to prompt consideration of Usher syndrome. 
Table 4 shows that nine of 13 patients (69.23%) with related 
diseases were older than 40 years.
Visual field examination was performed in only 
10 patients. All reports on automated perimetry revealed 
tubular visual fields with absolute annular scotoma.
Discussion
This study focused on patients treated in a hospital-based 
ophthalmologic outpatients unit. The hospital prevalence 
of retinitis pigmentosa (1.6/1000) would clearly not be 
representative of the entire Cameroonian population. In 
Caucasian countries, the prevalence in general population 
Table 1 Age distribution of patients with retinitis pigmentosa
Age (years) n %
,10  1 2.5
11–20 3 7.5
21–30 7 17.5
31–40 5 12.5
41–50 11 27.5
51–60 5 12.5
.60  8 20.0
Total 40 100
Unilateral
blindness, 1
Bilateral
blindness, 12 Low vision, 11
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Table 2 Distribution of blindness and low vision according to 
patient age
Age 
(years)
Visual pathology 
Bilateral 
blindness 
n (%)
Low vision 
n (%) 
Unilateral 
blindness  
n (%)
,10 0 (0.00)* 0 (0.00)* 0 (0.00)*
11–20 0 (0.00) 1 (33.33) 0 (0.00)
21–30 2 (28.57) 1 (14.29) 1 (14.29)
31–40 1 (20.00) 3 (60.00) 0 (0.00)
41–50 2 (18.18) 3 (27.27) 0 (0.00)
51–60 3 (60.00) 1 (20.00) 0 (0.00)
.60 4 (50.00) 2 (25.00) 0 (0.00)
Total 12 (30.00) 11 (27.50) 1 (2.50)
Table  3  Distribution  of  patients  according  to  associated 
pathologies
Associated pathologies n %
Cataract 4 10.00
ArMD 3 7.50
glaucoma 3 7.50
high myopia  2 5.00
isolated rP 27 67.50
Unilateral macular hole 1 2.50
Total 40 100.00
Abbreviations: ArMD, age-related macular degeneration; rP, retinitis pigmentosa.
studies is much lower, eg, 1/4756 in Maine, US5 and 1/3943 
in   Denmark.6 However, our prevalence is similar to that 
obtained by Kaya-Ganziami et al in a Congolese hospital.7
In our series, retinitis pigmentosa indiscriminately 
affected men and women (P . 0.05), in contrast with the 
findings of Kaya-Ganziami et al in Congo and Ukponmwan 
et al in Nigeria, where a male predominance of 63.6% and 
66.6%, respectively, has been reported.7,8
It is generally recognized that night blindness is one of 
the commonest complaints in retinitis pigmentosa,7,9–11 and 
the results of our study are consistent with this observation. 
Indeed, a drop in visual acuity and night blindness were the 
main reasons for consultation in our study. In addition, it 
should be noted that classical night blindness is often poorly 
recognized in childhood, and might be discovered only when 
in-depth investigations are conducted. Our series included 
few children, but this would not affect the conclusion we 
arrived at, ie, that a drop in visual acuity was a major cause 
of consultation in this series.
The average patient age of 43.3 ± 18.2 years in our series 
is older than that found by Ukponmwan et al in Nigeria 
and Tsujikawa et al in Japan, who reported an average age 
at   diagnosis of 36.7 and 35.1 years, respectively.8,12 This 
  difference may be explained by the delayed presentation of 
our patients, whose first recourse to treatment is often tradi-
tional practitioners and a tendency to come to hospital only 
when low vision and blindness are well advanced. Neverthe-
less, Grover et al13 found in their US series an average age at 
presentation of 41 years, which is similar to our findings.
In our study, 57.5% of patients had a significant bilateral 
decrease of visual acuity at the time of diagnosis (binocular 
blindness in 30% and low vision in 27.5%). This is similar 
to the data of Ukponmwan et al who reported binocular 
blindness in 50% and low vision in 26.7% of patients in their 
Nigerian series,7 and is also similar to the findings of Grover 
et al who reported a visual acuity ,1/10 in 25% of their 
patients suffering from retinitis pigmentosa,14 corresponding 
to severe low vision or blindness. In our series, the severity of 
visual impairment appears to be correlated with patient age. 
The older the subject, the more significant is the functional 
impairment, and thus we are left with an average age of about 
40 years for people with low vision and about 50 years for 
people with bilateral blindness.
In interpreting these outcomes, it is considered that there 
is a natural evolution of the disease whereby the patient starts 
to develop low vision approximately 10 years before becom-
ing totally blind. This is consistent with the findings of a US 
study by Marmor15 who found far visual acuity (interpreted as 
severe low vision or blindness) to be ,1/10 in more than 50% 
of patients with retinitis pigmentosa who were aged over 50 
years. The severity of visual impairment also depends on the 
mode of genetic transmission. In the US, it has been shown 
that patients with the clinical form of autosomal dominant 
retinitis pigmentosa suffer less from low vision and blindness 
compared with those having the X-linked recessive form of 
the disease.13,16 Unfortunately, no genetic study on this issue 
has ever been carried out in Cameroon where state-of-the-art 
science is still in its early stages.
Retinitis pigmentosa was isolated in 67.5% of cases, and 
no case of Usher syndrome was noted. This is consistent with 
a report by Kaya-Ganziami et al who found that 72.27% of 
cases of retinitis pigmentosa were isolated,7 whereas Grover 
et al13 found that only 47% were isolated. Associated illnesses 
were found in patients of relatively advanced age. Thus, all 
cases of cataracts, age-related macular degeneration, and 75% 
of glaucoma cases were identified in patients over 40 years. 
These potentially blinding diseases might worsen the visual 
prognosis for these patients and consequently affect their 
quality of life. In the US, Pruett found an association between 
retinitis pigmentosa and cataracts in 46.4% of cases,17 while 
Auffarth in Germany found this association in 40.7%–52.9% Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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of cases, depending on the definition of retinitis pigmen-
tosa used.18 Furthermore, Peng in China reported a 2.3% 
glaucoma prevalence in a series of patients with retinitis 
pigmentosa,19 which is three times lower than in our series 
where the prevalence of glaucoma was estimated at 7.5%. 
This finding provides additional evidence that chronic open 
angle glaucoma is more common in melanoderma subjects 
than in any other race.20 It is also known that myopia is com-
mon in retinitis pigmentosa, especially with the X-linked 
form, which is an even more frequent cause of consultation.21 
Myopia comprised 5% of associated pathologies in our series. 
The question arises as to whether the cases of high myopia 
that we recorded might in fact be associated with X-linked 
retinitis pigmentosa. Local genetic studies of this pathology 
in the future should throw more light on this issue.
The low rate of visual field assessment would be explained 
by the poor financial resources of most patients in our catch-
ment area, for whom the cost of this examination amounting 
to on average 30 Euros, would be prohibitive.
Limitations
Limitations of this study include the inadequate technical 
expertise in our unit which prevented some relevant tests 
being performed, in particular ERGs, which are of paramount 
importance in patients with retinitis pigmentosa. In the very 
early stages of the disease, the ERG response is either off or 
limited to a small photopic b-wave which disappears sud-
denly. There is no relationship between ERG and visual acu-
ity, in that an ERG may be off in the presence of good central 
visual acuity. It is possible to conduct this examination even 
in children aged younger than six years, in whom the visual 
field is hard to obtain.21 On the other hand, owing to the lack 
of ERG, we were not able to investigate retinitis pigmentosa 
in apparently healthy family members of affected individu-
als, which would have enabled us to know more about the 
mode of transmission of the disease. Fluorescein angiography 
also has diagnostic and prognostic importance in retinitis 
pigmentosa,21 but is not easily accessible in Cameroon.
Retinitis pigmentosa is not well known to the Cameroon 
population. Blindness which is not well explained (ie, not 
cataract or glaucoma) is often attributed to a curse from, for 
example, a neighbor. Therefore, cases of blindness recorded 
in the family history of a patient suffering from retinitis 
pigmentosa do not enable us to make a reliable connection 
between this disease and other cases of blindness in the 
family. Consequently, any assumptions about the mode 
of transmission are questionable. Families are large, and 
relatives tend not to attend ophthalmologic consultations 
requested by the physician because of an inability to get time 
off work, lack of interest, or lack of transport. It is therefore 
difficult to perform a thorough search for cases of retinitis 
pigmentosa within the same family and to determine the 
mode of transmission of the disease by either presumption 
or by genetic testing.
Conclusion
Visual impairment in retinitis pigmentosa is very common 
and becomes even more severe with aging. Concomitant ill-
nesses occur with age which may worsen the visual prognosis. 
Early screening for the disease may be the best strategy for 
its management, including both appropriate treatment and 
genetic counseling (although it has also been shown that 
more than 50% of subjects cannot confirm their heredity21). 
A study of the general population should be undertaken to 
identify the real prevalence of retinitis pigmentosa in our 
area. This research should be coupled with genetic studies in 
order to determine the mode of transmission, which strongly 
influences clinical expression of the disease and the visual 
prognosis.
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